Pioneering Minds Unite: Crystal Mackall, Drew Weissman, David R. Liu, Ira Mellman at PMWC25 CGT Oncology Track
We are thrilled to invite you to the Cell and Gene Therapy in Oncology Track at the upcoming Precision Medicine World Conference (PMWC) 2025 Silicon Valley – Feb 5-7. This track offers a unique opportunity to witness pioneering research and collaborative efforts that are reshaping the landscape of cancer treatment through innovative cell and gene therapies.
This year, we’re celebrating the brilliant minds behind cancer immunotherapy breakthroughs!
Crystal Mackall of Stanford University, recognized for her pioneering contributions to CAR T-cell therapy. Her recent work, highlighted in Nature, demonstrates the potential of engineered CD47 to protect T cells from macrophage-mediated clearance, significantly enhancing antitumor immunity.
Drew Weissman from Penn Medicine, our Pioneer Honoree and Nobel Laureate, celebrated for his groundbreaking advancements in mRNA vaccine technology, which has profoundly impacted cancer immunotherapy.
David R. Liu of the Broad Institute, for his transformative work in genome editing technologies. David will delve into the latest innovations in base editing and prime editing, offering new avenues for personalized cancer treatment. He shares, “Mutations in our genome cause thousands of genetic diseases, a long-standing goal of the life sciences has of course been to develop the ability to install, correct, or modify all types of pathogenic mutations so that we can study or potentially treat the broadest possible range of the corresponding diseases.”
The advancements in mRNA vaccines and CAR T-cell therapies will be explored in a session chaired by Ira Mellman formerly of Genentech. Their cumulative work represents a significant leap forward in harnessing the body’s immune system to fight cancer more effectively.
FEATURED SESSIONS:
• Base Editing, Prime Editing, and Targeted Gene Integration: Precision Therapeutic Genome Editing by David R. Liu
• Breakthroughs in Cancer Immunotherapy: mRNA Vaccines and CAR T-Cell Advances
o Chair: Ira Mellman, Formerly of Genentech
o Speakers: Drew Weissman, Crystal Mackall
• Next-Generation ADCs: Challenges and Innovations in Immunotherapy Combinations
o Chair: Sandhya Girish, Gilead
• Advances in Allogeneic Cell Therapies
o Chair: Elliot Norry, Adaptimmune
o Speakers: Larry Lamb, IN8bio; Indu Ramachandran, Century Therapeutics
• Advancing Precision Oncology
o Chair: Catriona Jamieson, UCSD Health
o Speakers: Irv Weisman, Stanford
• Advancements in Therapeutic Ultrasound for Precision Medicine
o Chair: Masha Stromme, EXACT Therapeutics
o Speakers: Bradford Elmer, Sanofi; John de Groot, UCSF; Raag Airan, Stanford
This track offers a comprehensive exploration of cutting-edge research and innovative strategies reshaping cancer treatment and precision medicine.
Don’t miss this opportunity to engage with these experts.
Register by Thursday to attend to secure the discounted rate.
Looking forward to seeing you at PMWC 2025!
Tal Behar
President & Co-founder, PMWC
PMWC 2025 Silicon Valley – February 5-7, 2025